跳至主要内容
临床试验/TCTR20171021001
TCTR20171021001招募中3 期

Efficacy of oral fosfomycin as a step down therapy after treatment for upper urinary tract infection caused by extended-spectrum b-lactamase-producing Escherichia coli

Research department, Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 140 人开始时间: 2017年10月21日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • 1. Admitted patient who was diagnosed as complicaed or non-complicated upper urinary tract infection in Siriraj hospital
  • 2. Urine culture grow 105 E.coli resisting to third generation cephalosporins and susceptible to fosfomycin (CLSI criteria)

排除标准

  • 1. Positive hemoculture
  • 2. Multiple organ infection
  • 3. Mixed urine culture
  • 4. Pregnant or breast feedind woman
  • 5. History of fosfomycin allergy
  • 6. Chronic kidney disease (eGFRB less than 30 mL/min/1.73m2)
  • 7. GI malabsorption
  • 8. Receive proper IV antibiotics more than 7 days before enrollment

研究者

发起方
Research department, Faculty of Medicine Siriraj Hospital, Mahidol University

相似试验